Skip to main content
All Posts By

Recuro Health

BlogMediaNews
October 4, 2021

Recuro Proud to Support 2021 SIIA Annual Meeting: Recuro CEO Michael Gorton Participates on Visionary Panel Exploring Future of Digital Health   

Recuro Proud to Support 2021 SIIA Annual Meeting: Recuro CEO Michael Gorton Participates on Visionary Panel Exploring Future of Digital Health SIIA’s 41st Annual National Educational Conference, October 3-5, 2021, Austin, TX was a great opportunity for Recuro Health to support SIIA and for Recuro’s rollout to employers of its multi-prong digital health solution, including COVID-19 antigen testing and vaccine tracking status capabilities. On a voluntary basis to all attendees, Recuro provided rapid COVID-19 antigen tests and a component to track testing status. A…
Blog
September 24, 2021

Recuro Health Supports SIIA Annual Meeting: Provides Voluntary COVID-19 Antigen Rapid Testing for Attendees: CEO Michael Gorton Panel Presenter

Recuro Health Supports SIIA Annual Meeting: Provides Voluntary COVID-19 Antigen Rapid Testing for Attendees: CEO Michael Gorton Panel Presenter Recuro Health is proud to support the SIIA annual conference by providing COVID-19 antigen rapid tests on a voluntary basis to all attendees during the three-day conference: SIIA’s 41st Annual National Educational Conference, October 3-5, 2021, Austin, TX. Recuro’s COVID-19 rapid…
Press Release
September 21, 2021

Recuro Health Supports SIIA Annual Meeting: Provides Voluntary COVID-19 Antigen Rapid Testing for Attendees, CEO Michael Gorton Panel Presenter

Recuro Health Supports SIIA Annual Meeting: Provides Voluntary COVID-19 Antigen Rapid Testing for Attendees, CEO Michael Gorton Panel Presenter DALLAS—BUSINESS WIRE)—Recuro Health(Recuro), an integrated digital health solutions company that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes approach, today announces that it will provide COVID-19 antigen rapid tests on a voluntary basis to…
Press Release
September 8, 2021

Recuro Health Acquires MyLifeIQ, Brings Epigenetics & Precision Medicine to its Rapidly Expanding Suite of Digital Health Solutions

Recuro Health Acquires MyLifeIQ, Brings Epigenetics & Precision Medicine to its Rapidly Expanding Suite of Digital Health Solutions DALLAS—(BUSINESS WIRE)—Recuro Health(Recuro), an integrated digital health solution that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes approach, today announces the acquisition of MyLifeIQ, an epigenetics platform that transitions healthcare to precision medicine. By simplifying and…
Media
September 7, 2021

Daily funding roundup – August 26th, 2021

Daily funding roundup - August 26th, 2021s Picsart has raised $130M; Neurogastrx landed $60M; Recuro Health secured $15M. Recuro Health is a Richardson, Tex.-based digital holistic health platform and has raised $15 million in Series A funding. Arch Venture Partners led the round, joined by earlier backers OLSF Ventures, Cortado Ventures, 1843 Capital and Sage Venture Partners. Read more. Continue reading…
Media
September 7, 2021

Today In Healthcare: WebMD Pairs With symplr, PYMNTS Ranks Telemedicine Apps And Recuro Health Gets $15M To Expand

Today In Healthcare: WebMD Pairs With symplr, PYMNTS Ranks Telemedicine Apps And Recuro Health Gets $15M To Expand Today in healthcare, WebMD partners with symplr on digital healthcare. Plus, PYMNTS unveils its monthly ranking of telemedicine apps and Recuro Health will use $15 million in Series A funding for digital expansion. Integrated digital wellness startup Recuro Health has raised $15 million in…
Blog
September 7, 2021

Recuro Health Raises $15 million in Series A Round Led by ARCH Venture Partners to Fund Next Generation of Digital Health Solutions

Recuro Health Raises $15 million in Series A Round Led by ARCH Venture Partners to Fund Next Generation of Digital Health Solutions At Recuro, we are always looking for ways to expand digital health solutions capabilities. That’s why we raised an oversubscribed seed-round fund in March 2021 and just five months later, announced a new $15 million Series A financing…